F. Worek, H. Thiermann, T. Wille. Oximes in Organophosphate Poisoning: 60 Years of Hope and Despair. Chemico-Biological Interactions 259 (2016) 93-98. https://doi.org/10.1016/j.cbi.2016.04.032 DOI: https://doi.org/10.1016/j.cbi.2016.04.032

[2] G. Šinko. Modeling of a Near-Attack Conformation of Oxime in Phosphorylated Acetylcholinesterase via a Reactivation Product, a Phosphorylated Oxime. Chemico-Biological Interactions 383 (2023) 110656. https://doi.org/10.1016/j.cbi.2023.110656 DOI: https://doi.org/10.1016/j.cbi.2023.110656

[3] T. Zorbaz, A. Braïki, N. Maraković, J. Renou, E. de la Mora, N. Maček Hrvat, M. Katalinić, I. Silman, J.L. Sussman, G. Mercey et al. Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration. Chemistry - A European Journal 24 (2018) 9675-9691. https://doi.org/10.1002/chem.201801394 DOI: https://doi.org/10.1002/chem.201801394

[4] Z. Kovarik, M. Katalinić, G. Šinko, J. Binder, O. Holas, Y.-S. Jung, L. Musilova, D. Jun, K. Kuča. Pseudo-Catalytic Scavenging: Searching for a Suitable Reactivator of Phosphorylated Butyrylcholinesterase. Chemico-Biological Interactions 187 (2010) 167-171. https://doi.org/10.1016/j.cbi.2010.02.023 DOI: https://doi.org/10.1016/j.cbi.2010.02.023

[5] T. Zorbaz, D. Malinak, K. Kuca, K. Musilek, Z. Kovarik. Butyrylcholinesterase Inhibited by Nerve Agents Is Efficiently Reactivated with Chlorinated Pyridinium Oximes. Chemico-Biological Interactions 307 (2019) 16-20. https://doi.org/10.1016/j.cbi.2019.04.020 DOI: https://doi.org/10.1016/j.cbi.2019.04.020

[6] Z. Kovarik, N. Maček Hrvat, J. Kalisiak, M. Katalinić, R.K. Sit, T. Zorbaz, Z. Radić, V.V. Fokin, K.B. Sharpless, P. Taylor. Counteracting Tabun Inhibition by Reactivation by Pyridinium Aldoximes That Interact with Active Center Gorge Mutants of Acetylcholinesterase. Toxicology and Applied Pharmacology 372 (2019) 40-46. https://doi.org/10.1016/j.taap.2019.04.007 DOI: https://doi.org/10.1016/j.taap.2019.04.007

[7] M. Katalinić, N. Maček Hrvat, K. Baumann, S. Morasi Piperčić, S. Makarić, S. Tomić, O. Jović, T. Hrenar, A. Miličević, D. Jelić et al. A Comprehensive Evaluation of Novel Oximes in Creation of Butyrylcholinesterase-Based Nerve Agent Bioscavengers. Toxicology and Applied Pharmacology 310 (2016) 195-204. https://doi.org/10.1016/j.taap.2016.09.015 DOI: https://doi.org/10.1016/j.taap.2016.09.015

[8] A. Zandona, M. Katalinić, G. Šinko, A. Radman Kastelic, I. Primožič, Z. Kovarik. Targeting Organophosphorus Compounds Poisoning by Novel Quinuclidine-3 Oximes: Development of Butyrylcholinesterase-Based Bioscavengers. Archives of Toxicology 94 (2020) 3157-3171. https://doi.org/10.1007/s00204-020-02811-5 DOI: https://doi.org/10.1007/s00204-020-02811-5

[9] T. Čadež, N. Maček Hrvat, G. Šinko, J. Kalisiak, Z. Radić, V.V. Fokin, K.B. Sharpless, P. Taylor, Z. Kovarik. Click-Chemistry-Derived Oxime Library Reveals Efficient Reactivators of Nerve Agent-Inhibited Butyrylcholinesterase Suitable for Pseudo-Catalytic Bioscavenging. Archives of Toxicology 99 (2025) 2107-2131. https://doi.org/10.1007/s00204-025-03985-6 DOI: https://doi.org/10.1007/s00204-025-03985-6

[10] A. Saxena, A.M.G. Redman, X. Jiang, O. Lockridge, B.P. Doctor. Differences in Active-Site Gorge Dimensions of Cholinesterases Revealed by Binding of Inhibitors to Human Butyrylcholinesterase. Chemico-Biological Interactions 119-120 (1999) 61-69. https://doi.org/10.1016/S0009-2797(99)00014-9 DOI: https://doi.org/10.1016/S0009-2797(99)00014-9

[11] Z. Kovarik, Z. Radić, H.A. Berman, V. Simeon-Rudolf, E. Reiner, P. Taylor. Mutant Cholinesterases Possessing Enhanced Capacity for Reactivation of Their Phosphonylated Conjugates †. Biochemistry 43 (2004) 3222-3229. https://doi.org/10.1021/bi036191a DOI: https://doi.org/10.1021/bi036191a

[12] N. Maraković, A. Knežević, I. Rončević, X. Brazzolotto, Z. Kovarik, G. Šinko. Enantioseparation, in Vitro Testing, and Structural Characterization of Triple-Binding Reactivators of Organophosphate-Inhibited Cholinesterases. Biochemical Journal 477 (2020) 2771-2790. https://doi.org/10.1042/BCJ20200192 DOI: https://doi.org/10.1042/BCJ20200192

[13] H. Abdi, L.J. Williams. Principal Component Analysis. WIREs Computational Statistics 2 (2010) 433-459. https://doi.org/10.1002/wics.101 DOI: https://doi.org/10.1002/wics.101

[14] D. Groth, S. Hartmann, S. Klie, J. Selbig. Principal Components Analysis in Computational Toxicology. Methods in Molecular Biology, B. Reisfeld, A. Mayeno, Eds., Humana Press, Totowa, NJ, 2002, vol 930, p. 527. https://doi.org/10.1007/978-1-62703-059-5_22 DOI: https://doi.org/10.1007/978-1-62703-059-5_22

[15] I.T. Jolliffe, J. Cadima. Principal Component Analysis: A Review and Recent Developments. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 374 (2016) 20150202. https://doi.org/10.1098/rsta.2015.0202 DOI: https://doi.org/10.1098/rsta.2015.0202

[16] A. Giuliani. The Application of Principal Component Analysis to Drug Discovery and Biomedical Data. Drug Discovery Today 22 (2017) 1069-1076. https://doi.org/10.1016/j.drudis.2017.01.005 DOI: https://doi.org/10.1016/j.drudis.2017.01.005

[17] N. Maček Hrvat, B. Puljko, R.K. Sit, K.; Ilić, D. Kolić, K. Mlinac-Jerkovic, S. Kalanj-Bognar, Z. Radić, K.B. Sharpless, P. Taylor et al. The Ionizing Zwitterionic Oxime Antidote Attenuates Gliosis in Mice Exposed to Sarin. Chemico-Biological Interactions 421 (2025) 111767. https://doi.org/10.1016/j.cbi.2025.111767 DOI: https://doi.org/10.1016/j.cbi.2025.111767

[18] Z. Radić, R.K. Sit, Z. Kovarik, S. Berend, E. Garcia, L. Zhang, G. Amitai, C. Green, B. Radić, V.V. Fokin. et al. Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases. Journal of Biological Chemistry 287 (2012) 11798-11809. https://doi.org/10.1074/jbc.M111.333732 DOI: https://doi.org/10.1074/jbc.M111.333732

[19] A. Bosak, D.M. Opsenica, G. Šinko, M. Zlatar, Z. Kovarik. Structural Aspects of 4-Aminoquinolines as Reversible Inhibitors of Human Acetylcholinesterase and Butyrylcholinesterase. Chemico- Biological Interactions 308 (2019) 101-109. https://doi.org/10.1016/j.cbi.2019.05.024 DOI: https://doi.org/10.1016/j.cbi.2019.05.024

[20] V. Pehar, D. Kolić, A. Zandona, G. Šinko, M. Katalinić, V. Stepanić, Z. Kovarik. Selected Herbicides Screened for Toxicity and Analysed as Inhibitors of Both Cholinesterases. Chemico- Biological Interactions 379 (2023) 110506. https://doi.org/10.1016/j.cbi.2023.110506 DOI: https://doi.org/10.1016/j.cbi.2023.110506

[21] D. Kolić, G. Šinko. Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin. International Journal of Molecular Sciences 25 (2024) 6310. https://doi.org/10.3390/ijms25126310 DOI: https://doi.org/10.3390/ijms25126310

[22] H. Pajouhesh, G.R. Lenz. Medicinal Chemical Properties of Successful Central Nervous System Drugs. NeuroRX 2 (2005) 541-553. https://doi.org/10.1602/neurorx.2.4.541 DOI: https://doi.org/10.1602/neurorx.2.4.541

[23] S.S. Bharate, S. Mignani, R.A. Vishwakarma. Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis. Journal of Medicinal Chemistry 61 (2018) 10345-10374. https://doi.org/10.1021/acs.jmedchem.7b01922 DOI: https://doi.org/10.1021/acs.jmedchem.7b01922

[24] W.J. Egan, G. Lauri. Prediction of Intestinal Permeability. Advanced Drug Delivery Reviews 54 (2002) 273-289. https://doi.org/10.1016/S0169-409X(02)00004-2 DOI: https://doi.org/10.1016/S0169-409X(02)00004-2

[25] G. Šinko. Assessment of Scoring Functions and in Silico Parameters for AChE-Ligand Interactions as a Tool for Predicting Inhibition Potency. Chemico- Biological Interactions 308 (2019) 216-223. https://doi.org/10.1016/j.cbi.2019.05.047 DOI: https://doi.org/10.1016/j.cbi.2019.05.047

[26] T. Jednačak, V. Stepanić, I. Habinovec, I. Mikulandra, K. Smokrović, H. Čipčić Paljetak, M. Bukvić, J. Parlov Vuković, I. Grgičević, L. Divjak, K. Zangger, P. Novak. Anti-infective macrozones: design, biological evaluation and structure-activity relationships. ADMET and DMPK 14 (2026) 3139. https://doi.org/10.5599/admet.3139 DOI: https://doi.org/10.5599/admet.3139